6388 related articles for article (PubMed ID: 3405144)
1. Backscatter measurements from a single seed of 125I for ophthalmic plaque dosimetry.
Luxton G; Astrahan MA; Petrovich Z
Med Phys; 1988; 15(3):397-400. PubMed ID: 3405144
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry for 125I seed (model 6711) in eye plaques.
Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds.
Luxton G; Astrahan MA; Liggett PE; Neblett DL; Cohen DM; Petrovich Z
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):167-76. PubMed ID: 3391814
[TBL] [Abstract][Full Text] [Related]
5. Palladium 103 ophthalmic plaque radiotherapy.
Finger PT; Moshfeghi DM; Ho TK
Arch Ophthalmol; 1991 Nov; 109(11):1610-3. PubMed ID: 1755746
[TBL] [Abstract][Full Text] [Related]
6. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
7. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
[TBL] [Abstract][Full Text] [Related]
8. Dose rate determination for 125I seeds.
Chiu-Tsao ST; Anderson LL; O'Brien K; Sanna R
Med Phys; 1990; 17(5):815-25. PubMed ID: 2233567
[TBL] [Abstract][Full Text] [Related]
9. [Development and dosimetry of a 125 iodine applicator for brachytherapy of intraocular tumors].
Alberti W; Pothmann B; Bornfeld N; Foerster MH; Harder D; Hermann KP; Muskalla K; Tabor P; Sack H; Wessing A
Fortschr Ophthalmol; 1990; 87(2):201-5. PubMed ID: 2358279
[TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
[TBL] [Abstract][Full Text] [Related]
11. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
Poder J; Corde S
Med Phys; 2013 Dec; 40(12):121709. PubMed ID: 24320495
[TBL] [Abstract][Full Text] [Related]
12. The dosimetry of 125I seed eye plaques.
Weaver KA
Med Phys; 1986; 13(1):78-83. PubMed ID: 3814235
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
Ballester F; Granero D; Pérez-Calatayud J; Casal E; Puchades V
Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
[TBL] [Abstract][Full Text] [Related]
14. Experimental measurements and Monte Carlo calculations for (103)Pd dosimetry of the 12 mm COMS eye plaque.
Saidi P; Sadeghi M; Tenreiro C
Phys Med; 2013 May; 29(3):286-94. PubMed ID: 22592132
[TBL] [Abstract][Full Text] [Related]
15. Conformal episcleral plaque therapy.
Astrahan MA; Luxton G; Pu Q; Petrovich Z
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):505-19. PubMed ID: 9308957
[TBL] [Abstract][Full Text] [Related]
16. Design and dosimetric considerations of a modified COMS plaque: the reusable "seed-guide" insert.
Astrahan MA; Szechter A; Finger PT
Med Phys; 2005 Aug; 32(8):2706-16. PubMed ID: 16193802
[TBL] [Abstract][Full Text] [Related]
17. Dose parameters of 125I and 192Ir seed sources.
Weaver KA; Smith V; Huang D; Barnett C; Schell MC; Ling C
Med Phys; 1989; 16(4):636-43. PubMed ID: 2770636
[TBL] [Abstract][Full Text] [Related]
18. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
Finger PT; Berson A; Szechter A
Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
[TBL] [Abstract][Full Text] [Related]
19. 125I eye plaque dose distribution including penumbra characteristics.
de la Zerda A; Chiu-Tsao ST; Lin J; Boulay LL; Kanna I; Kim JH; Tsao HS
Med Phys; 1996 Mar; 23(3):407-18. PubMed ID: 8815384
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
